BANTAM
Device Facts
| Record ID | K091242 |
|---|---|
| Device Name | BANTAM |
| Applicant | Altimate Medical, Inc. |
| Product Code | INO · Physical Medicine |
| Decision Date | Jul 6, 2009 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 890.3110 |
| Device Class | Class 2 |
| Attributes | Therapeutic, Pediatric |
Indications for Use
To assist persons who have difficulty rising from a seated position to a standing position and is indicated for persons weighing between 50 - 100 lbs., including pediatrics.
Device Story
EasyStand Bantam is a standing frame/electric positioning chair for individuals with physical disabilities. Device supports user from sitting to standing position; functions as desk/workstation in seated or standing positions. Available in two models accommodating heights 28"-40" (up to 50 lbs) and 28"-54" (up to 100 lbs). Operation involves manual or electric seat elevation; electric lift activated by hand pendant; gas cylinder allows caregiver-actuated elevation. Includes optional supine position for users unable to tolerate upright posture. Used in clinical or home settings to provide weight-bearing position and exercise body. Benefits include assistance with rising, improved positioning, and workstation utility.
Clinical Evidence
No clinical data provided; bench testing only.
Technological Characteristics
Electric positioning chair; manual or electric lift mechanism; gas cylinder for seat elevation; hand pendant control; optional supine positioning. Dimensions vary by model (height ranges 28"-40" or 28"-54").
Indications for Use
Indicated for pediatric and other patients weighing 50-100 lbs. who have difficulty transitioning from a seated to a standing position.
Regulatory Classification
Identification
An electric positioning chair is a device with a motorized positioning control that is intended for medical purposes and that can be adjusted to various positions. The device is used to provide stability for patients with athetosis (involuntary spasms) and to alter postural positions.
Special Controls
(1) Appropriate analysis and non-clinical testing must demonstrate that the safety controls are adequate to ensure safe use of the device and prevent user falls from the device in the event of a device failure; (2) Appropriate analysis and non-clinical testing must demonstrate the ability of the device to withstand the rated user weight load with an appropriate factor of safety; (3) Appropriate analysis and non-clinical testing must demonstrate the longevity of the device to withstand external forces applied to the device and provide the user with an expected service life of the device; (4) Appropriate analysis and non-clinical testing must demonstrate proper environments of use and storage of the device to maximize the longevity of the device; (5) Appropriate analysis and non-clinical testing (such as that outlined in the currently FDA-recognized editions of ANSI/AAMI/ES60601-1, “Medical Electrical Equipment—Part 1: General Requirements for Basic Safety and Essential Performance,” and ANSI/AAMI/IEC 60601-1-2, “Medical Electrical Equipment—Part 1-2: General Requirements for Basic Safety and Essential Performance—Collateral Standard: Electromagnetic Disturbances—Requirements and Tests”) must validate electromagnetic compatibility and electrical safety; (6) Appropriate analysis and non-clinical testing (such as that outlined in the currently FDA-recognized editions of ANSI/AAMI/ISO 10993-1, “Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing Within a Risk Management Process,” ANSI/AAMI/ISO 10993-5, “Biological Evaluation of Medical Devices—Part 5: Tests for In Vitro Cytotoxicity,” and ANSI/AAMI/ISO 10993-10, “Biological Evaluation of Medical Devices—Part 10: Tests for Irritation and Skin Sensitization”) must validate that the skin-contacting components of the device are biocompatible; (7) Appropriate analysis and non-clinical testing (such as that outlined in the currently FDA-recognized editions of IEC 62304, “Medical Device Software—Software Life Cycle Processes”) must validate the software life cycle and that all processes, activities, and tasks are implemented and documented; (8) Appropriate analysis and non-clinical testing must validate that the device components are found to be non-flammable; (9) Appropriate analysis and non-clinical testing must validate that the battery in the device (if applicable) performs as intended over the anticipated service life of the device; and (10) Adequate patient labeling is provided to the user to document proper use and maintenance of the device to ensure safe use of the device by the patient in the intended use environment.
Predicate Devices
- Altimate Medical EasyStand Evolv (K062402)